News

Elis Pharmaceuticals received the license for Vitaros from Apricus Biosciences in January of 2011, having exclusive rights to sell the drug in the Gulf Countries and part of

Boca Pharmacal CEO Robert Edwards said this is the company’s first approval this year and it is expecting a second before the end of the first quarter. "As

After integration with the MedInformatix-powered system, MedRevenu’s clients have achieved a revenue gain of 30% within the first three to four months of operation. MedRevenu actively tracks denials

The MyLax Cleanse Formula provides fiber and probiotics with primary laxative support and soothing herbs for individuals experiencing digestive complaints. The stimulating laxatives include Senna, Aloe and Cascara

FDA-approved Eylea injection is a recombinant fusion protein, consisting of portions of human Vascular Endothelial Growth Factor (VEGF) receptors 1 and 2 extracellular domains fused to the Fc

The joint venture will manage advanced-stage clinical trials in Russia of new pharmaceuticals and other products that will support regulatory approval of these products in Russia, the US

An international randomized double-blind placebo controlled Study COU-AA-302 included 1,088 patients who were randomized to receive Zytiga 1,000mg once daily plus prednisone 5mg administered twice daily or placebo

The cardiopatch study was conducted by researchers from the Faculty of Medicine of the Geneva University in collaboration with Ecole Polytechnique Federale de Lausanne (EPFL). Using a protein

According to the study, patients with more severe symptoms achieved a greater improvement following treatment with the ToleroMune T-cell vaccine than those on placebo (p=0.05). Therandomized, double-blind studywas